表紙
市場調査レポート

世界の幹細胞市場分析

Analysis of the Global Stem Cell Market

発行 Frost & Sullivan 商品コード 315676
出版日 ページ情報 英文 171 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
世界の幹細胞市場分析 Analysis of the Global Stem Cell Market
出版日: 2014年10月07日 ページ情報: 英文 171 Pages
概要

当レポートでは、世界の幹細胞市場について調査し、製品、技術、地域および用途別の分析、主要地域・主要国市場の分析、主な臨床上のマイルストーン、臨床的イベント、注目企業および戦略的パートナーシップなどについてまとめ、お届けいたします。

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 市場区分

  • 幹細胞の市場区分

第4章 市場区分:製品別

  • 成体幹細胞:間葉幹細胞
  • 間葉幹細胞:市場概要
  • 間葉幹細胞:臨床用途
  • 生体幹細胞:造血幹細胞
  • 生体幹細胞:神経幹細胞
  • 生体幹細胞:臍帯幹細胞
  • 生体幹細胞:iPS細胞
  • ヒトES細胞

第5章 市場区分:技術別

  • 細胞取得技術
  • 細胞生産技術

第6章 市場区分:用途別

  • 幹細胞:用途別
  • 幹細胞:用途別、主な調査結果

第7章 規制状況および政策

  • 世界の幹細胞政策
  • 世界の幹細胞規制

第8章 競合プレイブック

  • 主要ステークホルダー
  • 合併, 買収, および提携の評価

第9章 企業プロファイル

  • Advanced Cell Technology, Inc.
  • Aldagen, Inc.
  • Athersys, Inc.
  • Cellerant Therapeutics, Inc.

第10章 促進要因・抑制要因:幹細胞市場 全体

  • 世界の主な促進要因:サマリー
  • 世界の主な促進要因の説明
  • 世界の主な抑制要因:サマリー
  • 世界の主な抑制要因の説明

第11章 予測および動向:幹細胞市場全体

  • 測定
  • 予測の前提条件
  • 収益予測
  • 収益予測の議論
  • 世界市場の展望

第12章 世界の幹細胞市場:区分別分析

  • 市場区分
  • 臍帯血幹細胞:収益予測
  • iPS細胞:収益予測
  • iPS細胞:収益予測の議論

第13章 地域別の市場規模・予測:北米

  • 北米:収益予測
  • 収益予測の議論

第14章 欧州

第15章 アジア太平洋地域

第16章 アジア太平洋地域の分析:インド

  • 幹細胞市場概要
  • 幹細胞バンク市場概要
  • 幹細胞移植市場概要
  • 幹細胞関連規制&政策
  • 幹細胞資金
  • 幹細胞の競合概要
  • 主な促進要因の概要
  • 主な抑制要因の概要
  • 新しい市場機会
  • 合併, 買収および提携評価

第17章 オーストラリア

第18章 タイ

第19章 シンガポール

第20章 韓国

第21章 マレーシア

第22章 日本

第23章 結論および提言

第24章 付録

図表リスト

目次
Product Code: P805-52

Key to Transform the Future of Diagnostic and Therapeutic Medicine

This study investigates the global stem cell market for the period from 2013 to 2018. The geographic regions covered in the study are the North America, Europe and APAC, followed by a detailed Asia Pacific Region Analysis, which covers countries such as India, Australia, Thailand, Singapore, South Korea, Malaysia and Japan. The stem cell market has been broadly segmented into four, namely by products, technology, region and application. The study discusses regulatory policies within stem cell research, key business updates, analysis of risk factors, and strategic recommendations. Additionally, key clinical milestones, clinical events, companies to watch, and a strategic partnership assessment in the global stem cell market have been included.

Key Questions This Study Will Answer

  • What are the types of stem cells preferred in the medical industry? Does the geographical locations limit stem cell research?
  • What important trends are affecting the market currently and would impact in future?
  • What are the key factors driving the market and the barriers that need to be resolved?
  • How will the structure of the market change over time?
  • Who are the industry participants and what about their product developments?
  • What are the scientific challenges and risk factors in this industry?

Table of Contents

1. EXECUTIVE SUMMARY

Executive Summary

  • 1. Key Findings
  • 2. Key Findings (continued)
  • 3. Scope and Segmentation
  • 4. Key Questions This Study Will Answer
  • 5. Measurements
  • 6. CEO's Perspective
  • 7. New Market Opportunities
  • 8. Key Companies to Watch
  • 9. Three Big Predictions

2. MARKET OVERVIEW

Market Overview

  • 1. Definition-Key Terminology
  • 2. Stem Cell Market Overview
  • 3. Porter's 5 Forces Analysis
  • 4. Porter's 5 Forces Analysis (continued)
  • 5. Porter's 5 Forces Analysis (continued)
  • 6. Recent Developments in Stem Cell Research

3. MARKET SEGMENTATION

Market Segmentation

  • 1. Stem Cell Market Segmentation

4. MARKET SEGMENTATION BY PRODUCTS

Market Segmentation by Products

  • 1. Adult Stem Cells-Mesenchymal Stem Cells
  • 2. Mesenchymal Stem Cells-Market Overview
  • 3. Mesenchymal Stem Cells-Clinical Applications
  • 4. Adult Stem Cells-Hematopoietic Stem Cells
  • 5. Adult Stem Cells-Neural Stem Cells
  • 6. Adult Stem Cells-Umbilical Cord Stem Cells
  • 7. Adult Stem Cells-Induced Pluripotent Stem Cells (iPSC)
  • 8. Human Embryonic Stem Cells

5. MARKET SEGMENTATION BY TECHNOLOGY

Market Segmentation by Technology

  • 1. Cell Acquisition Technique
  • 2. Cell Production Technique

6. MARKET SEGMENTATION BY APPLICATION

Market Segmentation by Application

  • 1. Stem Cells by Application
  • 2. Stem Cells by Application (continued)
  • 3. Stem Cells by Application-Key Findings

7. REGULATORY SCENARIO AND POLICIES

Regulatory Scenario and Policies

  • 1. Global Stem Cell Policies
  • 2. Global Stem Cell Policies (continued)
  • 3. Global Stem Cell Regulations

8. COMPETITIVE PLAYBOOK

Competitive Playbook

  • 1. Key Stakeholders
  • 2. Merger, Acquisition, and Partnership Assessment
  • 3. Merger, Acquisition, and Partnership Assessment (continued)
  • 4. Merger, Acquisition, and Partnership Assessment (continued)
  • 5. Merger, Acquisition, and Partnership Assessment (continued)

9. PROFILE OF THE COMPANIES

Profile of the Companies

  • 1. Advanced Cell Technology, Inc.
  • 2. Aldagen, Inc.
  • 3. Athersys, Inc.
  • 4. Cellerant Therapeutics, Inc.

10. DRIVERS AND RESTRAINTS-TOTAL STEM CELL MARKET

Drivers and Restraints-Total Stem Cell Market

  • 1. Global Key Drivers Summary
  • 2. Global Key Drivers Explained
  • 3. Global Key Drivers Explained (continued)
  • 4. Global Key Restraints Summary
  • 5. Global Key Restraints Explained
  • 6. Global Key Restraints Explained (continued)

11. FORECASTS AND TRENDS-TOTAL STEM CELL MARKET

Forecasts and Trends-Total Stem Cell Market

  • 1. Measurements
  • 2. Forecast Assumptions
  • 3. Revenue Forecast
  • 4. Revenue Forecast Discussion
  • 5. Global Market Perspective

12. GLOBAL STEM CELL MARKET SEGMENT ANALYSIS

Global Stem Cell Market Segment Analysis

  • 1. Market Segmentation
  • 2. Umbilical Cord Blood Stem Cells-Revenue Forecast
  • 3. Induced Pluripotent Stem Cells-Revenue Forecast
  • 4. Induced Pluripotent Stem Cells-Revenue Forecast Discussion

13. MARKET SIZE AND FORECASTS BY GEOGRAPHY-NORTH AMERICA

Market Size and Forecasts by Geography-North America

  • 1. North America-Revenue Forecast
  • 2. Revenue Forecast Discussion

14. EUROPE

Europe

  • 1. Europe-Revenue Forecast
  • 2. Revenue Forecast Discussion

15. ASIA-PACIFIC

Asia-Pacific

  • 1. Asia-Pacific-Revenue Forecast
  • 2. Revenue Forecast Discussion

16. ASIA-PACIFIC REGION ANALYSIS-INDIA

Asia-Pacific Region Analysis-India

  • 1. Indian Stem Cell Market Overview
  • 2. Indian Stem Cell Banking Market Overview
  • 3. Indian Stem Cell Banking Market Overview (continued)
  • 4. Indian Stem Cell Transplant Market Overview
  • 5. Regulations & Policies on Stem Cell in India
  • 6. Regulations & Policies on Stem Cell in India (continued)
  • 7. Stem Cell Funding in India
  • 8. India Stem Cell Competitive Overview
  • 9. India Key Drivers Summary
  • 10. India Key Restraints Summary
  • 11. New Market Opportunities in India
  • 12. Merger, Acquisition and Partnership Assessment

17. AUSTRALIA

Australia

  • 1. Australia Stem Cell Market Overview
  • 2. Australia Stem Cell Banking Market Overview
  • 3. Australia Stem Cell Banking Market Overview (continued)
  • 4. Regulations & Policies on Stem Cell in Australia
  • 5. Regulations & Policies on Stem Cell in Australia (continued)
  • 6. Stem Cell Funding in Australia
  • 7. Stem Cell Funding in Australia (continued)
  • 8. Australia Stem Cell Competitive Overview
  • 9. Australia Key Drivers Summary
  • 10. Australia Key Restraints Summary
  • 11. New Market Opportunities in Australia
  • 12. Recent Developments in Stem Cell Research in Australia

18. THAILAND

Thailand

  • 1. Thailand Stem Cell Market Overview
  • 2. Thailand Stem Cell Banking Market Overview
  • 3. Thailand Stem Cell Banking Market Overview (continued)
  • 4. Thailand Stem Cell Transplant Market Overview
  • 5. Regulations & Policies on Stem Cell in Thailand
  • 6. Stem Cell Funding in Thailand
  • 7. Thailand Stem Cell Competitive Overview
  • 8. Thailand Key Drivers Summary
  • 9. Thailand Key Restraints Summary
  • 10. New Market Opportunities in Thailand
  • 11. Recent Developments in Stem Cell Research in Thailand

19. SINGAPORE

Singapore

  • 1. Singapore Stem Cell Market Overview
  • 2. Singapore Stem Cell Banking Market Overview
  • 3. Singapore Stem Cell Banking Market Overview (continued)
  • 4. Singapore Stem Cell Transplant Market Overview
  • 5. Regulations & Policies on Stem Cell in Singapore
  • 6. Stem Cell Funding in Singapore
  • 7. Singapore Stem Cell Competitive Overview
  • 8. Singapore Key Drivers Summary
  • 9. Singapore Key Restraints Summary
  • 10. New Market Opportunities in Singapore
  • 11. Recent Developments in Stem Cell Research in Singapore

20. SOUTH KOREA

South Korea

  • 1. South Korean Stem Cell Market Overview
  • 2. South Korean Stem Cell Banking Market Overview
  • 3. Regulations & Policies on Stem Cell in South Korea
  • 4. Stem Cell Funding in South Korea
  • 5. South Korea Stem Cell Competitive Overview
  • 6. South Korea One of the Few to Introduce Stem Cell Products in Therapeutics
  • 7. South Korea Key Drivers Summary
  • 8. South Korea Key Restraints Summary
  • 9. New Market Opportunities in South Korea
  • 10. Recent Developments in Stem Cell Research in South Korea

21. MALAYSIA

Malaysia

  • 1. Malaysian Stem Cell Market Overview
  • 2. Malaysian Stem Cell Banking Market Overview
  • 3. Malaysian Stem Cell Banking Market Overview (continued)
  • 4. Malaysia Stem Cell Competitive Overview
  • 5. Regulations & Policies on Stem Cell in Malaysia
  • 6. Stem Cell Funding in Malaysia
  • 7. Malaysia Key Drivers Summary
  • 8. Malaysia Key Restraints Summary
  • 9. New Market Opportunities in Malaysia
  • 10. Recent Developments in Stem Cell Research in Malaysia

22. JAPAN

Japan

  • 1. Japan Stem Cell Market Overview
  • 2. Japan Stem Cell Banking Market Overview (continued)
  • 3. Timeline of Pluripotent Stem Cell Research in Japan
  • 4. Regulations & Policies on Stem Cell in Japan
  • 5. Stem Cell Funding in Japan
  • 6. Japan Stem Cell Competitive Overview
  • 7. Japan Key Drivers Summary
  • 8. Japan Key Restraints Summary
  • 9. Recent Developments in Stem Cell Research in Japan

23. CONCLUSION AND RECOMMENDATION

Conclusion and Recommendation

  • 1. Conclusion and Recommendation
  • 2. Legal Disclaimer

24. APPENDIX

Appendix

  • 1. Methodology
  • 2. List of Exhibits
  • 3. List of Exhibits (Continued)

List of Exhibits

  • Total Stem Cell Market: Market Engineering Measurements, Global, 2013
  • Total Stem Cell Market: Game-changing Strategies, Global, 2013
  • Total Stem Cell Market: Mesenchymal Stem Cells by Source, 2013
  • Total Stem Cell Market: Percent Breakdown of Companies by Therapeutic Approach, Global, 2013
  • Total Stem Cell Market: Market Outlook, Global, 2012-2013
  • Total Stem Cell Market: Timeline of Key Events-Advanced Cell Technology, Inc., Global, 2010-2014
  • Total Stem Cell Market: Pipeline Assets-Advanced Cell Technology, Inc., Global, 2013
  • Total Stem Cell Market: Timeline of Key Events-Aldagen, Inc., Global, 2013
  • Total Stem Cell Market: Pipeline Assets-Aldagen, Inc., Global, 2013
  • Total Stem Cell Market: Timeline of Key Events-Athersys, Inc., Global, 2013
  • Total Stem Cell Market: Pipeline Assets-Athersys, Inc., Global, 2013
  • Total Stem Cell Market: Timeline of Key Events-Cellerant Therapeutics, Inc., Global, 2013
  • Total Stem Cell Market: Pipeline Assets-Cellerant Therapeutics, Inc., Global, 2013
  • Total Stem Cell Market: Key Market Drivers, Global, 2013
  • Total Stem Cell Market: Key Market Restraints, Global, 2013
  • Total Stem Cell Market: Market Engineering Measurements, Global, 2013
  • Total Stem Cell Market: Revenue Forecast, Global, 2013-2018
  • Total Stem Cell Market: Percent Breakdown by Geographic Region, Global, 2013
  • Total Stem Cell Market: Percent Revenue Breakdown, Global, 2013
  • Umbilical Cord Blood Stem Cell Market: Revenue Forecast, Global, 2013-2018
  • Induced Pluripotent Stem Cells Market: Revenue Forecast, Global, 2013-2018
  • Stem Cell Market: Revenue Forecast, North America, 2013-2018
  • Stem Cell Market: Revenue Forecast, Europe, 2013-2018
  • Stem Cell Market: Revenue Forecast, Asia-Pacific, 2013-2018
  • Stem Cell Market: Revenue, APAC, 2013
  • Stem Cell Market: Private Stem Cell Banking, India, 2013
  • Stem Cell Banking Business Model, India, 2013
  • Stem Cell Market: Key Market Drivers, India, 2013
  • Stem Cell Market: Key Market Restraints, India, 2013
  • Stem Cell Market: Private Stem Cell Banking, Australia, 2013
  • Stem Cell Banking Business Model, Australia, 2013
  • Stem Cell Market: Key Market Drivers, Australia, 2013
  • Stem Cell Market: Key Market Restraints, Australia, 2013
  • Stem Cell Market: Private Stem Cell Banking, Thailand, 2013
  • Stem Cell Banking Business Model, Thailand, 2013
  • Stem Cell Market: Key Market Drivers, Thailand, 2013
  • Stem Cell Market: Key Market Restraints, Thailand, 2013
  • Stem Cell Market: Private Stem Cell Banking, Singapore, 2013
  • Stem Cell Banking Business Model, Singapore, 2013
  • Stem Cell Market: Key Market Drivers, Singapore, 2013
  • Stem Cell Market: Key Market Restraints, Singapore, 2013
  • Stem Cell Market: Private Stem Cell Banking, South Korea, 2013
  • Stem Cell Market: Key Market Drivers, South Korea, 2013
  • Stem Cell Market: Key Market Restraints, South Korea, 2013
  • Stem Cell Market: Private Stem Cell Banking, Malaysia, 2013
  • Stem Cell Banking Business Model, Malaysia, 2013
  • Stem Cell Market: Key Market Drivers, Malaysia, 2013
  • Stem Cell Market: Key Market Restraints, Malaysia, 2013
  • Stem Cell Banking Business Model, Japan, 2013
  • Pluripotent Stem Cell Research: Timeline of Key Events, Japan, 2000-2012
  • Stem Cell Market: Key Market Drivers, Japan, 2013
  • Stem Cell Market: Key Market Restraints, Japan, 2013
Back to Top